FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2035351580> ?p ?o ?g. }

• W2035351580 endingPage "706.e2" @default.
• W2035351580 startingPage "700" @default.
• W2035351580 abstract "The prophylactic use of protease inhibitors in patients undergoing ERCP is still controversial. Our purpose was to evaluate the efficacy of protease inhibitors in preventing ERCP-associated complications.Meta-analysis; randomized trials that evaluated the efficacy of protease inhibitors were identified.A total of 4966 patients were evaluated.ERCP-associated pancreatitis, hyperamylasemia, abdominal pain, and death.Eighteen studies (19 cohorts) met the inclusion criteria. Overall results for protease inhibitors showed a significant but small risk reduction in ERCP-associated pancreatitis (pooled risk difference [RD]: -0.029; 95% CI, -0.051 to -0.008 and the number needed to treat, 34.5; 95% CI, 19.6-125). Subgroup analysis in 8 high-quality studies showed a borderline significant efficacy (pooled RD, -0.027; 95% CI, -0.051 to -0.004). Subgroup analysis in 8 gabexate studies did not show significant efficacy (pooled RD, -0.030; 95% CI, -0.062 to 0.003). Subgroup analysis in 5 ulinastatin studies was significant (pooled RD, -0.035; 95% CI, -0.063 to -0.006). Two high-quality studies on ulinastatin yielded nonsignificant results. Analyses for the other outcomes were all nonsignificant. Sensitivity analysis showed that the effect size and level of statistical significance were decreased with increasing study quality.At present, there is no solid evidence to support the use of protease inhibitors to prevent ERCP-associated complications. Although overall and ulinastatin subgroup analyses showed a small risk reduction for pancreatitis, it seems very possible that low-quality primary studies produced a veneer of efficacy." @default.
• W2035351580 created "2016-06-24" @default.
• W2035351580 creator A5009641737 @default.
• W2035351580 creator A5032526114 @default.
• W2035351580 date "2011-04-01" @default.
• W2035351580 modified "2023-10-01" @default.
• W2035351580 title "Protease inhibitors for preventing complications associated with ERCP: an updated meta-analysis" @default.
• W2035351580 cites W1510489616 @default.
• W2035351580 cites W1551220641 @default.
• W2035351580 cites W1561812037 @default.
• W2035351580 cites W1964435302 @default.
• W2035351580 cites W1967246198 @default.
• W2035351580 cites W1969993577 @default.
• W2035351580 cites W1983991013 @default.
• W2035351580 cites W1986215651 @default.
• W2035351580 cites W1991995513 @default.
• W2035351580 cites W1993348473 @default.
• W2035351580 cites W2005426660 @default.
• W2035351580 cites W2005904298 @default.
• W2035351580 cites W2008030713 @default.
• W2035351580 cites W2018261935 @default.
• W2035351580 cites W2040949160 @default.
• W2035351580 cites W2048402908 @default.
• W2035351580 cites W2053881081 @default.
• W2035351580 cites W2055220713 @default.
• W2035351580 cites W2062119339 @default.
• W2035351580 cites W2079878657 @default.
• W2035351580 cites W2083186305 @default.
• W2035351580 cites W2083579911 @default.
• W2035351580 cites W2089115083 @default.
• W2035351580 cites W2107328434 @default.
• W2035351580 cites W2115094071 @default.
• W2035351580 cites W2123617929 @default.
• W2035351580 cites W2125435699 @default.
• W2035351580 cites W2137366845 @default.
• W2035351580 cites W2144091893 @default.
• W2035351580 cites W2157823046 @default.
• W2035351580 cites W2168046530 @default.
• W2035351580 cites W2316926039 @default.
• W2035351580 cites W2320210611 @default.
• W2035351580 cites W4293242440 @default.
• W2035351580 doi "https://doi.org/10.1016/j.gie.2010.09.022" @default.
• W2035351580 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21145053" @default.
• W2035351580 hasPublicationYear "2011" @default.
• W2035351580 type Work @default.
• W2035351580 sameAs 2035351580 @default.
• W2035351580 citedByCount "39" @default.
• W2035351580 countsByYear W20353515802012 @default.
• W2035351580 countsByYear W20353515802013 @default.
• W2035351580 countsByYear W20353515802014 @default.
• W2035351580 countsByYear W20353515802016 @default.
• W2035351580 countsByYear W20353515802017 @default.
• W2035351580 countsByYear W20353515802018 @default.
• W2035351580 countsByYear W20353515802019 @default.
• W2035351580 countsByYear W20353515802020 @default.
• W2035351580 countsByYear W20353515802021 @default.
• W2035351580 countsByYear W20353515802022 @default.
• W2035351580 countsByYear W20353515802023 @default.
• W2035351580 crossrefType "journal-article" @default.
• W2035351580 hasAuthorship W2035351580A5009641737 @default.
• W2035351580 hasAuthorship W2035351580A5032526114 @default.
• W2035351580 hasConcept C126322002 @default.
• W2035351580 hasConcept C141071460 @default.
• W2035351580 hasConcept C168563851 @default.
• W2035351580 hasConcept C170835558 @default.
• W2035351580 hasConcept C181199279 @default.
• W2035351580 hasConcept C185592680 @default.
• W2035351580 hasConcept C187960798 @default.
• W2035351580 hasConcept C2775967933 @default.
• W2035351580 hasConcept C2781246285 @default.
• W2035351580 hasConcept C2909698591 @default.
• W2035351580 hasConcept C3017906399 @default.
• W2035351580 hasConcept C44249647 @default.
• W2035351580 hasConcept C55493867 @default.
• W2035351580 hasConcept C71924100 @default.
• W2035351580 hasConcept C82789193 @default.
• W2035351580 hasConcept C90924648 @default.
• W2035351580 hasConcept C95190672 @default.
• W2035351580 hasConceptScore W2035351580C126322002 @default.
• W2035351580 hasConceptScore W2035351580C141071460 @default.
• W2035351580 hasConceptScore W2035351580C168563851 @default.
• W2035351580 hasConceptScore W2035351580C170835558 @default.
• W2035351580 hasConceptScore W2035351580C181199279 @default.
• W2035351580 hasConceptScore W2035351580C185592680 @default.
• W2035351580 hasConceptScore W2035351580C187960798 @default.
• W2035351580 hasConceptScore W2035351580C2775967933 @default.
• W2035351580 hasConceptScore W2035351580C2781246285 @default.
• W2035351580 hasConceptScore W2035351580C2909698591 @default.
• W2035351580 hasConceptScore W2035351580C3017906399 @default.
• W2035351580 hasConceptScore W2035351580C44249647 @default.
• W2035351580 hasConceptScore W2035351580C55493867 @default.
• W2035351580 hasConceptScore W2035351580C71924100 @default.
• W2035351580 hasConceptScore W2035351580C82789193 @default.
• W2035351580 hasConceptScore W2035351580C90924648 @default.
• W2035351580 hasConceptScore W2035351580C95190672 @default.
• W2035351580 hasIssue "4" @default.
• W2035351580 hasLocation W20353515801 @default.
• W2035351580 hasLocation W20353515802 @default.

• next